Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up

BACKGROUND: Prospective, population-based study of an 8-year follow up. To determine the direct cost of diabetic retinopathy [DR], evaluating our screening programme and the cost of treating DR, focusing on diabetic macular oedema [DMO] after anti-vascular endothelial growth factor [anti-VEGF] treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Romero-Aroca, Pedro, de la Riva-Fernandez, Sofia, Valls-Mateu, Aida, Sagarra-Alamo, Ramon, Moreno-Ribas, Antonio, Soler, Nuria, Puig, Domenec
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973531/
https://www.ncbi.nlm.nih.gov/pubmed/27491545
http://dx.doi.org/10.1186/s12886-016-0318-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973531/
https://www.ncbi.nlm.nih.gov/pubmed/27491545
http://dx.doi.org/10.1186/s12886-016-0318-x

Ejemplares similares